Shasun Pharmaceuticals Ltd(Merged)

Shasun Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shasun Pharmaceuticals Ltd(Merged)

₹ 429 5.40%
17 Nov 2015
shasun.com BSE: 524552
About

Shasun Pharmaceuticals Limited (SPL) is an India-based company, which is a supplier of development and manufacturing services for intermediates, active pharmaceutical ingredients (API) and finished dosage. The Company is also into product development and provides contract research and manufacturing services.

[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 429
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 67.2
  • Dividend Yield 0.00 %
  • ROCE 7.94 %
  • ROE 5.91 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 6.38 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 10.9% over past five years.
  • Company has a low return on equity of 11.6% over last 3 years.
  • Dividend payout has been low at 11.6% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015
272 271 276 227 297 325 363 314 320 325 358 334 339
241 251 253 232 266 290 323 297 301 292 317 303 302
Operating Profit 31 20 23 -5 30 35 40 17 19 33 41 31 37
OPM % 11% 7% 8% -2% 10% 11% 11% 5% 6% 10% 11% 9% 11%
11 8 7 9 7 3 3 2 4 2 12 1 4
Interest 6 10 5 8 9 11 14 12 12 16 13 12 12
Depreciation 13 12 16 13 15 15 16 12 10 12 13 14 15
Profit before tax 21 6 9 -17 13 13 13 -5 1 7 27 5 15
Tax % 17% -28% -50% -61% 0% -1% 23% 0% 2% 0% 23% 24% 11%
18 8 13 -7 13 13 10 -5 0 6 22 4 13
EPS in Rs 3.22 1.49 2.34 -1.16 2.36 2.30 1.84 -0.80 0.04 1.02 3.69 0.57 1.95
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 TTM
348 763 809 749 784 834 1,066 1,084 1,207 1,314 1,356
292 689 797 863 771 763 943 967 1,098 1,195 1,214
Operating Profit 55 73 12 -113 13 71 123 117 109 119 141
OPM % 16% 10% 1% -15% 2% 9% 12% 11% 9% 9% 10%
17 19 59 32 57 22 41 18 23 21 19
Interest 5 10 15 22 30 32 44 32 50 63 52
Depreciation 23 26 31 38 38 38 41 53 59 47 54
Profit before tax 43 57 24 -141 2 24 80 50 23 30 54
Tax % 15% 8% -1% -3% -88% -13% -26% -5% -32% 21%
37 53 25 -137 4 27 101 53 30 24 45
EPS in Rs 10.94 5.10 -28.38 0.78 5.49 18.25 9.37 5.34 3.95 7.23
Dividend Payout % 22% 16% 20% 0% 128% 5% 13% 16% 19% 0%
Compounded Sales Growth
10 Years: %
5 Years: 11%
3 Years: 7%
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: 30%
3 Years: -35%
TTM: 107%
Stock Price CAGR
10 Years: 3%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 18%
3 Years: 12%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015
Equity Capital 10 10 10 10 10 10 11 11 11 12
Reserves 168 212 230 97 108 74 211 261 291 367
79 192 257 339 327 329 353 506 692 739
94 219 167 219 219 235 285 266 332 364
Total Liabilities 351 632 663 664 663 648 860 1,044 1,327 1,482
175 214 255 269 244 248 278 365 383 529
CWIP 2 21 55 35 30 12 52 81 114 76
Investments 5 0 0 0 0 0 0 1 7 16
169 397 352 360 389 387 529 598 823 861
Total Assets 351 632 663 664 663 648 860 1,044 1,327 1,482

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015
31 -6 58 -34 37 59 51 35 40 84
-32 -78 -106 -21 10 -32 -77 -161 -164 -145
-9 91 43 54 -40 -28 32 117 131 51
Net Cash Flow -9 8 -5 -0 7 -1 5 -9 7 -9

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015
Debtor Days 80 90 81 91 90 69 79 89 106 97
Inventory Days 115 182 103 97 89 108 90 113 122 128
Days Payable 83 200 105 158 152 137 141 140 159 152
Cash Conversion Cycle 112 72 79 30 27 40 28 62 69 72
Working Capital Days 94 90 89 72 77 64 63 89 103 118
ROCE % 20% 9% -27% 3% 13% 19% 12% 8% 8%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

Annual reports